Activist investor Sachem Head Capital Management significantly increased its investment in Warner Bros. Discovery during the fourth quarter, drawing fresh attention to the media and entertainment company’s high-profile strategic moves. According to a recent Securities and Exchange Commission filing, the hedge fund more than doubled its holdings to nearly 8 million shares by year-end, making Warner Bros. Discovery one of its top 10 U.S. stock positions.
The increased stake comes at a pivotal time for Warner Bros. Discovery, which recently agreed to sell its streaming and studios business to Netflix. The transaction has reshaped the competitive landscape in the media sector and sparked strong reactions from investors and rivals alike. With a market value of approximately $70 billion, Warner Bros. Discovery remains a key player in global entertainment, streaming, and content production.
Meanwhile, Paramount Skydance is intensifying efforts to acquire Warner Bros. Discovery after its hostile takeover bid was rejected last month. Paramount has continued to apply pressure, urging the company’s leadership to reconsider discussions in case its offer becomes more attractive than Netflix’s proposal. The situation has raised the possibility of a boardroom battle, with Paramount suggesting it could attempt to replace certain directors. It even floated the idea that a senior executive from Pentwater Capital Management, one of Warner Bros. Discovery’s largest shareholders, could serve as a compelling board candidate.
In addition to expanding its Warner Bros. Discovery position, Sachem Head disclosed new investments in EchoStar, acquiring 5.2 million shares. The hedge fund also initiated positions in Carvana and Live Nation Entertainment, signaling broader interest in telecommunications, online retail, and live entertainment stocks.
Although regulatory filings are backward-looking, they remain closely watched by market participants seeking insights into hedge fund strategies, trending stocks, and potential takeover targets within the U.S. equity market.


AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
How Marco Pharma International Preserves German Homeopathic Traditions in America
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase 



